Latest On Gerresheimer AG (GRRMF):
| Date/Time | Type | Description | Signal | Details |
|---|---|---|---|---|
| 2023-06-08 06:06 EST | Dividend | A dividend of $1.25 has been announced on Feb 27, 2023. It will be paid Jun 12, 2023 with an ex-dividend date of Jun 8, 2023. | Neutral |  |
| 2023-04-06 23:42 EST | News | Gerresheimer AG Non-GAAP EPS of €0.71, revenue of €457.8M | N/A | |
| 2023-04-06 23:42 EST | News | Gerresheimer AG (GRRMF) Q1 2023 Earnings Call Transcript | N/A | |
| 2023-02-25 16:03 EST | News | Gerresheimer AG (GRRMF) Q4 2022 Earnings Call Transcript | N/A | |
| 2023-02-23 10:05 EST | News | Gerresheimer AG Q4 adjusted EBITDA up Y/Y | N/A | |
| 2022-10-12 14:39 EST | News | Gerresheimer AG Non-GAAP EPS of €1.15, revenue of €473M | N/A | |
| 2022-10-12 14:38 EST | News | Gerresheimer AG 2022 Q3 - Results - Earnings Call Presentation | N/A | |
| 2022-10-12 14:38 EST | News | Gerresheimer AG (GRRMF) Q3 2022 Earnings Call Transcript | N/A | |
| 2022-07-15 07:22 EST | News | Gerresheimer AG's (GRRMF) CEO Dietmar Siemssen on Q2 2022 Results - Earnings Call Transcript | N/A | |
| 2022-07-14 01:15 EST | News | Gerresheimer AG 2022 Q2 - Results - Earnings Call Presentation | N/A | |
| 2022-07-13 10:13 EST | News | Gerresheimer reaffirms FY22 guidance after solid Q2 | N/A | |
| 2022-07-13 10:13 EST | News | Gerresheimer AG (GRRMF) CEO Dietmar Siemssen on Q2 2022 Results - Earnings Call Transcript | N/A | |
| 2022-06-09 06:05 EST | Dividend | A dividend of $1.25 has been announced on Feb 22, 2022. It will be paid Jun 13, 2022 with an ex-dividend date of Jun 9, 2022. | Neutral | |
| 2022-04-07 17:54 EST | News | Gerresheimer AG GAAP EPS of $0.34, revenue of $370.8M | N/A | |
| 2022-04-07 17:54 EST | News | Gerresheimer AG (GRRMF) CEO Dietmar Siemssen on Q1 2022 Results - Earnings Call Transcript | N/A | |
| 2022-02-21 02:39 EST | News | Gerresheimer AG 2021 Q4 - Results - Earnings Call Presentation | N/A | |
| 2022-02-18 06:38 EST | News | Gerresheimer AG Non-GAAP EPS of €4.13, revenue of €1.5B | N/A | |
| 2022-02-18 06:38 EST | News | Gerresheimer AG (GRRMF) CEO Dietmar Siemssen on Q4 2021 Results - Earnings Call Transcript | N/A | |
| 2021-10-12 17:59 EST | News | Gerresheimer AG 2021 Q3 - Results - Earnings Call Presentation | N/A | |
| 2021-10-12 17:59 EST | News | Gerresheimer AG (GRRMF) CEO Dietmar Siemssen On Q3 2021 Results - Earnings Call Transcript | N/A | |
| 2021-07-22 14:57 EST | News | Gerresheimer AG (GRRMF) CEO Dietmar Siemssen on Q2 2021 Results - Earnings Call Transcript | N/A | |
| 2021-06-10 06:15 EST | Dividend | A dividend of $1.25 has been announced on Apr 27, 2021. It will be paid Jun 14, 2021 with an ex-dividend date of Jun 10, 2021. | Neutral | |
| 2021-04-08 21:30 EST | News | Gerresheimer AG reports Q1 results; outlook | N/A | |
| 2021-02-19 13:28 EST | Financials | Company financials have been released. | Neutral | |
| 2021-02-19 06:17 EST | Earnings Estimate | An EPS average of $5.11 is estimated for the 2022 year. | Buy | |
| 2020-12-04 18:25 EST | Financials | Company financials have been released. | Neutral | |
| 2020-11-26 23:46 EST | Financials | Company financials have been released. | Neutral | |
| 2020-11-08 02:41 EST | Financials | Company financials have been released. | Neutral | |
| 2020-11-07 19:02 EST | Financials | Company financials have been released. | Neutral | |
| 2020-10-16 09:51 EST | News | (Exclusive) Gerresheimer: A Low But COVID-Proof Dividend With Plenty Of Upside Potential | N/A | |
| 2020-10-14 10:52 EST | Financials | Company financials have been released. | Neutral | |
| 2020-09-26 15:53 EST | Financials | Company financials have been released. | Neutral | |
| 2020-09-17 08:23 EST | Financials | Company financials have been released. | Neutral | |
| 2020-08-31 14:36 EST | Financials | Company financials have been released. | Neutral | |
| 2020-08-14 11:56 EST | Financials | Company financials have been released. | Neutral | |
| 2020-08-06 15:35 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-30 19:45 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-30 07:44 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-29 23:57 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-28 17:03 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-28 14:55 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-27 15:34 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-23 20:25 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-15 03:58 EST | News | Gerresheimer AG reports Q2 results | N/A | |
| 2020-07-09 11:46 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-01 19:26 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-01 03:17 EST | Financials | Company financials have been released. | Neutral | |
| 2020-06-25 06:05 EST | Dividend | A dividend of $1.2 has been announced on Feb 24, 2020. It will be paid Jun 29, 2020 with an ex-dividend date of Jun 25, 2020. | Neutral | |
| 2020-06-25 01:13 EST | News | Gerresheimer AG declares EUR 1.20 dividend | N/A | |
| 2020-06-19 15:19 EST | Financials | Company financials have been released. | Neutral | |
About Gerresheimer AG (GRRMF):
Gerresheimer AG, together with its subsidiaries, manufactures and sells specialty glass, plastic products, and drug delivery-devices and solutions primarily worldwide. It operates through three divisions: Plastics & Devices, Primary Packaging Glass, and Advanced Technologies. The Plastics & Devices division offers drug delivery systems, including inhalers, pen systems, and injection systems; sterile and non-sterile syringe systems for the pharmaceutical and biotech industries; and disposables for various analysis systems that are used in laboratories and medical practices, quick tests for patients in medical practices or hospitals, skin-prick aids and lancets for diabetics, disposables, and components for dialysis machines, and catheters and surgical devices. It also provides containers for the delivery of tablets and powders, liquid dosages, ophthalmic and rhinological applications, parenteral packaging applications, oral prescription medications, and cosmetics. The Primary Packaging Glass division offers glass primary packaging for pharma and cosmetics industries, such as ampoules, cartridges, vials, syrup and dropper bottles, tablet jars, and wide-neck jars, as well as injection, infusion, and transfusion bottles; flacons and pots for fragrances, deodorants, and care and decorative cosmetics; and bottles and jars for spirits and food. The Advanced Technologies division develops drug delivery products and platforms, such as micro pumps, which are used to self-administer medication for heart failure or Parkinson's for pharmaceutical and biotech customers. The company was founded in 1864 and is headquartered in Düsseldorf, Germany.
General
- Name Gerresheimer AG
- Symbol GRRMF
- Type Common Stock
- Exchange OTCGREY
- Currency USD
- Country USA
- Full Time Employees 9,880
- Fiscal Year EndNovember
- Web URLhttp://www.gerresheimer.com
Financials
- Most Recent Quarter 2020-11-30
- Current Year EPS Estimate $4.46
- Next Year EPS Estimate $5.11
- Profit Margin 6%
- Return on Assets 4%
- Return on Equity 10%
- Revenue Per Share $0
- Gross Profit 439.09 million
- Quarterly Earnings Growth 9.3%
Highlights
- Market Capitalization 3.42 billion
Share Statistics
- Shares Outstanding 31.4 million
- Shares Float 31.4 million
- % Held by Insiders <1%
- % Held by Institutions 73.06%
Technicals
- Beta 1.01
- 52 Week High $118.07
- 52 Week Low $75.36
- 50 Day Moving Average 107.33
- 200 Day Moving Average 111.57
Dividends
- Dividend Date N/A
- ExDividend Date N/A
- Dividend Yield 0%
Gerresheimer AG (GRRMF) Dividend Calendar:
| Ex-Dividend Date | Payment Date | Record Date | Declared Date | Amount |
|---|
Gerresheimer AG (GRRMF) Earnings History:
Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.
| Quarter Date | Report Date | Actual Revenue | Reported EPS | EPS Estimate | Deviation from Estimate |
|---|---|---|---|---|---|
| 2020-11-30 | 2020-11-30 | $N/A | $1.31 | $1.35 | -2.96% |
| 2020-08-31 | 2020-11-30 | $N/A | $1.14 | $0.94 | 21.41% |
| 2020-05-31 | 2020-08-31 | $N/A | $0.96 | $1.03 | -6.32% |
| 2020-02-29 | 2020-05-31 | $N/A | $1.02 | $0.48 | 113.38% |
| 2019-11-30 | 2020-02-29 | $408.39 million | $0.15 | $1.40 | -89.61% |
| 2019-08-31 | 2019-11-30 | $393.28 million | -$2.92 | $0.94 | -410.49% |
| 2019-05-31 | 2019-08-31 | $398.69 million | $0.65 | $0.94 | -31.22% |
| 2019-02-28 | 2019-05-31 | $350.81 million | $1.66 | $0.56 | 195.89% |
| 2018-11-30 | 2019-02-28 | $442.59 million | $3.58 | $1.45 | 147.12% |
| 2018-08-31 | 2018-11-30 | $410.26 million | $1.55 | $0.97 | 60.26% |
| 2018-05-31 | 2018-08-31 | $388.92 million | $0.68 | $0.96 | -29.06% |
| 2018-02-28 | 2018-05-31 | $354.06 million | $0.70 | $1.01 | -30.8% |
| 2017-11-30 | 2018-02-28 | $445.71 million | $1.89 | $1.50 | 26.03% |
| 2017-08-31 | 2017-11-30 | $394.75 million | $1.43 | $1.04 | 37.88% |
| 2017-05-31 | 2017-08-31 | $339.53 million | $0.97 | $1.02 | -4.84% |
| 2017-02-28 | 2017-05-31 | $302.81 million | $0.88 | $0.67 | 31% |
| 2016-11-30 | 2017-02-28 | $357.62 million | $0.44 | $1.20 | -63.68% |
| 2016-08-31 | 2016-10-06 | $1.19 | $1.03 | 15.53% | |
| 2016-05-31 | 2016-08-31 | $1.08 | $1.10 | -1.87% | |
| 2016-02-29 | 2016-05-31 | $0.97 | $0.66 | 46.92% | |
| 2015-11-30 | 2016-02-29 | $0.52 | $1.23 | -57.94% | |
| 2015-08-31 | 2015-10-08 | $0.85 | $0.81 | 4.94% | |
| 2015-05-31 | 2015-08-31 | $0.65 | $0.82 | -20.79% | |
| 2015-02-28 | 2015-05-31 | $0.71 | $0.37 | 91.51% | |
| 2014-11-30 | 2015-02-28 | $0.39 | $1.06 | -62.88% | |
| 2014-08-31 | 2014-11-30 | $0.79 | $0.76 | 3.7% | |
| 2014-05-31 | 2014-08-31 | $0.76 | $0.67 | 13.72% | |
| 2014-02-28 | 2014-05-31 | $0.84 | $0.32 | 161.72% | |
| 2013-11-30 | 2014-02-28 | $0.39 | $1.00 | -60.62% | |
| 2013-08-31 | 2013-11-30 | $1.01 | $0.00 | ||
| 2013-05-31 | 2013-08-31 | $0.76 | $0.00 | ||
| 2013-02-28 | 2013-05-31 | $0.44 | $0.00 | ||
| 2012-11-30 | 2013-02-28 | $0.36 | $0.00 | ||
| 2012-08-31 | 2012-11-30 | $1.04 | $0.00 | ||
| 2012-05-31 | 2012-08-31 | $0.54 | $0.00 | ||
| 2012-02-29 | 2012-05-31 | $0.64 | $0.00 | ||
| 2011-11-30 | 2012-02-29 | $0.24 | $0.00 | ||
| 2011-08-31 | 2011-11-30 | $0.61 | $0.00 | ||
| 2011-05-31 | 2011-08-31 | $0.83 | $0.00 | ||
| 2011-02-28 | 2011-05-31 | $0.55 | $0.00 | ||
| 2010-11-30 | 2011-02-28 | $0.27 | $0.00 |
Gerresheimer AG (GRRMF) Company Financial Statements:
Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.
Income Statement:
| Date | Nov 30 2020 | Aug 31 2020 | May 31 2020 | Mar 31 2020 | Feb 29 2020 |
|---|---|---|---|---|---|
| Research Development | N/A | N/A | N/A | N/A | N/A |
| Income Before Tax | N/A | N/A | N/A | N/A | N/A |
| Selling General Administrative | N/A | N/A | N/A | N/A | N/A |
| Gross Profit | N/A | N/A | N/A | N/A | N/A |
| Ebit | N/A | N/A | N/A | N/A | N/A |
| Operating Income | N/A | N/A | N/A | N/A | N/A |
| Income Tax Expense | 18.52 million | 12.69 million | 11.31 million | 11.31 million | 3.04 million |
| Total Revenue | N/A | N/A | N/A | N/A | N/A |
| Cost of Revenue | N/A | N/A | N/A | N/A | N/A |
| Total Other Income Expense Net | N/A | N/A | N/A | N/A | N/A |
| Net Income From Continuing Operations | N/A | N/A | N/A | N/A | N/A |
| Net Income Applicable to Common Shares | 30.04 million | 25.4 million | 28.99 million | 28.99 million | 4.58 million |
Cash Flow:
| Date | Aug 31 2020 | May 31 2020 | Mar 31 2020 | Feb 29 2020 | Dec 31 2019 |
|---|---|---|---|---|---|
| Investments | N/A | N/A | N/A | N/A | N/A |
| Change to Liabilities | 12.62 million | 12.81 million | 12.81 million | -83.23 million | -75.27 million |
| Total Cash Flow from Investing Activities | -28.97 million | -30.69 million | -30.69 million | -36.27 million | -32.81 million |
| Net Borrowings | -1.03 million | -12.62 million | -12.62 million | 77.3 million | 69.91 million |
| Total Cash Flow from Financial Activities | N/A | N/A | N/A | N/A | N/A |
| Change to Operating Activities | 1.59 million | 74000 | 74000 | -1.84 million | -1.67 million |
| Change in Cash | N/A | N/A | N/A | N/A | N/A |
| Total Cash from Operating Activities | 66.7 million | 75.7 million | 75.7 million | -49.88 million | -45.11 million |
| Depreciation | N/A | N/A | N/A | N/A | N/A |
| Other Cash Flow from Investing Activities | 13.42 million | 54000 | 54000 | 122733.3 | 111000 |
| Change to Inventory | N/A | N/A | N/A | N/A | N/A |
| Change to Account Receivables | N/A | N/A | N/A | N/A | N/A |
| Other Cash Flow from Financing Activities | 209000 | N/A | N/A | N/A | N/A |
| Change to Net Income | 791000 | 9.84 million | 9.84 million | -813799.2 | -736000 |
| Capital Expenditures | N/A | N/A | N/A | N/A | N/A |
Balance Sheet:
| Date | Nov 30 2020 | Aug 31 2020 | May 31 2020 | Mar 31 2020 | Feb 29 2020 |
|---|---|---|---|---|---|
| Total Liabailities | N/A | N/A | N/A | N/A | N/A |
| Total Stockholder Equity | N/A | N/A | N/A | N/A | N/A |
| Other Current Liabilities | 355.46 million | 136.35 million | N/A | N/A | N/A |
| Total Assets | N/A | N/A | N/A | N/A | N/A |
| Common Stock | 31.4 million | 31.4 million | 31.4 million | N/A | 34.72 million |
| Other Current Assets | N/A | N/A | N/A | 31.4 million | N/A |
| Retained Earnings | 473.76 million | 447.75 million | 460.04 million | 460.04 million | 477.2 million |
| Other Liabilities | 1.14 billion | 292.1 million | 301.86 million | 301.86 million | 340.41 million |
| Other Assets | 19.03 million | 18.66 million | 21.48 million | 21.48 million | 32.21 million |
| Cash | N/A | N/A | N/A | N/A | N/A |
| Total Current Liabilities | 579.46 million | 909.73 million | N/A | N/A | N/A |
| Other Stockholder Equity | -135.15 million | -137.75 million | -88.39 million | -88.39 million | -56.91 million |
| Property, Plant & Equipment | 763.1 million | 714.64 million | 713.79 million | 713.79 million | 801.76 million |
| Total Current Assets | 551.37 million | 558.19 million | N/A | N/A | N/A |
| Long Term Investments | N/A | N/A | N/A | N/A | N/A |
| Net Tangible Assets | -390.57 million | -427.4 million | -411.81 million | -411.81 million | -466.01 million |
| Short Term Investments | N/A | N/A | N/A | N/A | N/A |
| Long Term Debt | N/A | N/A | N/A | N/A | N/A |
| Inventory | 189.98 million | 207.93 million | N/A | N/A | N/A |
| Accounts Payable | 211.62 million | 153.14 million | N/A | N/A | N/A |
Gerresheimer AG (GRRMF) Chart:
Gerresheimer AG (GRRMF) News:
Below you will find a list of latest news for Gerresheimer AG (GRRMF) from major news sources. You can filter the results to only show news from a specific source.
No recent news available
Gerresheimer AG (GRRMF) Options:
A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.
| Expiration Date | Strike | Last Price | Type | Volume | Open Interest | Implied Volatility | In The Money | Change | Change Percent |
|---|
Gerresheimer AG (GRRMF) SEC Filings:
An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.
| Date | Form Type | Form Name | Link |
|---|